Evaluate the Usefulness of Mental Health e-Learning

July 29, 2025 updated by: McMaster University

Randomized Trial to Evaluate the Usefulness of Mental Health e-Learning

In this proposal, the investigators plan to study the impact of In this proposal, we plan to study the impact of e-learning on mental health literacy and stigma related to anxiety and depression. Participants will be randomized to one of four groups - Depression e-Learning A, Depression e-Learning B, Anxiety e-Learning A, and Anxiety e-Learning B. All participants will be given access to all e-learning at the conclusion of the study.

Study Overview

Study Type

Interventional

Enrollment (Actual)

125

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8S4L8
        • McMaster University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Live in Canada
  • 45 years of age and over
  • Good command of the English language
  • Access to email and high speed internet
  • Comfortable using email and internet

Exclusion Criteria:

  • Lives outside of Canada
  • Not 45 years of age or over
  • Does not speak English,
  • Does not have access to email or high speed internet
  • Is not comfortable using email of internet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Depression e-Learning A

Participants in Depression e-Learning A will be provided e-learning about depression, consisting of following components:

  1. One multimedia e-learning lesson on depression;
  2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.

1. One multimedia e-learning lesson on depression; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.

Experimental: Anxiety e-Learning A

Participants in Anxiety e-Learning A will be provided e-learning about anxiety, consisting of following components:

  1. One multimedia e-learning lesson on anxiety;
  2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
Experimental: Depression e-Learning B

Participants in Depression e-Learning B will be provided e-learning about depression, consisting of following components:

  1. One multimedia e-learning lesson on depression;
  2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.

1. One multimedia e-learning lesson on depression; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.

Experimental: Anxiety e-Learning B

Participants in Anxiety e-Learning B will be provided e-learning about anxiety, consisting of following components:

  1. One multimedia e-learning lesson on anxiety;
  2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in the Depression Literacy Questionnaire
Time Frame: 0, 2, 4 weeks
The Depression Literacy Questionnaire assesses mental health literacy specific to depression. The questionnaire consists of 22 items which are true or false. Respondents can answer each item with one of three options - true, false, or I don't know. Each correct response receives one point. Higher scores indicate higher depression literacy.
0, 2, 4 weeks
Change from baseline in the Anxiety Literacy Questionnaire
Time Frame: 0, 2, 4 weeks
The Anxiety Literacy Questionnaire assesses mental health literacy specific to anxiety. The questionnaire consists of 22 items which are true or false. Respondents can answer each item with one of three options - true, false, or I don't know. Each correct response receives one point. Higher scores indicate higher depression literacy.
0, 2, 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in the Depression Stigma Scale
Time Frame: 0, 2, 4 weeks
The Depression Stigma Scale is a 9-item assessment designed to measure stigma associated with depression with two subscales: personal and perceived. The Personal Stigma Subscale measures stigma in the respondents' own attitudes towards depression by asking them to indicate how strongly they personally agree with nine statements about depression. The Perceived Stigma Subscale measures the respondent's perception about the attitudes of others towards depression by asking them to indicate what they think most other people believe about the same nine statements. Responses to each item are measured on a five-point scale (ranging from zero 'strongly disagree' to four 'strongly agree'). Higher scores indicate higher levels of depression stigma.
0, 2, 4 weeks
Change from baseline in the Generalized Anxiety Stigma Scale
Time Frame: 0, 2, 4 weeks
The Generalised Anxiety Stigma Scale is analogous, but designed to measure stigma associated with anxiety disorders. It has two subscales: personal and perceived. The Personal Stigma Subscale measures stigma in the respondents' own attitudes towards anxiety disorders by asking them to indicate how strongly they personally agree with 10 statements about anxiety disorders. The Perceived Stigma Subscale measures the respondent's perception about the attitudes of others towards anxiety disorders by asking them to indicate what they think most other people believe about the same 10 statements. Responses to each item are measured on a five-point scale (ranging from zero 'strongly disagree' to four 'strongly agree'). Higher scores indicate higher levels of anxiety stigma.
0, 2, 4 weeks
Participant satisfaction
Time Frame: 2 weeks
A custom satisfaction questionnaire data adapted from the Information Assessment Method For All (IAM4all) will be collected and saved to assess satisfaction with the intervention.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 6, 2024

Primary Completion (Actual)

September 12, 2024

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

April 26, 2024

First Submitted That Met QC Criteria

April 26, 2024

First Posted (Actual)

May 1, 2024

Study Record Updates

Last Update Posted (Actual)

July 30, 2025

Last Update Submitted That Met QC Criteria

July 29, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Levinson_AFP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Depression e-Learning A

Subscribe